Hong Kong

Last Updated 5 March 2021.

1 Vaccine Approved for Use in Hong Kong

• Pfizer/BioNTech
  BNT162b2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 68 countries

  12 trials in 9 countries

  RNA

0 Vaccines in Clinical Trials in Hong Kong